Espindola, M. S., Habiel, D. M., & Hogaboam, C. M. (2018). Reply to D’Alessandro-Gabazza et al: Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor. Am J Respir Crit Care Med.
Citação norma ChicagoEspindola, Milena S., David M. Habiel, and Cory M. Hogaboam. "Reply to D’Alessandro-Gabazza Et Al: Risks of Treating Idiopathic Pulmonary Fibrosis With a TAM Receptor Kinase Inhibitor." Am J Respir Crit Care Med 2018.
MLA引文Espindola, Milena S., David M. Habiel, and Cory M. Hogaboam. "Reply to D’Alessandro-Gabazza Et Al: Risks of Treating Idiopathic Pulmonary Fibrosis With a TAM Receptor Kinase Inhibitor." Am J Respir Crit Care Med 2018.
警告：這些引文格式不一定是100％准確.